Earnings PotentialPositive TETON-2 data has led to an increase in the price target for MNKD shares to $11, from $9.
Revenue GrowthAfrezza's strong growth in net revenue reflects the initial positive effect from increased promotional efforts, with management expecting the trend to continue.
Strategic AcquisitionsThe acquisition of scPharmaceuticals Inc. is viewed positively for MNKD shares, as it diversifies the revenue base and provides more control over future revenues.